/Companies

Emulsi Biotech AB

1 known investors

Find your way into Emulsi Biotech AB

Sign up to find every way you can get introduced to Emulsi Biotech AB

  • Your email: who you already know at Emulsi Biotech AB, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Emulsi Biotech AB team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Emulsi develops NanoLIPID™, a natural lipid technology that self-assembles into nano-structures for encapsulating active pharmaceutical ingredients, nutraceuticals, and bioactive compounds. The platform targets oral drug delivery, cosmetics, and nutraceutical applications.

Investors · 1

Frequently asked questions

What does Emulsi Biotech AB do?
Emulsi develops NanoLIPID™, a natural lipid technology that self-assembles into nano-structures for encapsulating active pharmaceutical ingredients, nutraceuticals, and bioactive compounds. The platform targets oral drug delivery, cosmetics, and nutraceutical applications.
Who are Emulsi Biotech AB's investors?
Emulsi Biotech AB's investors include BSV Ventures.